“Matching-Adjusted Indirect Comparison of the Efficacy of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis Beyond Week 16”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 1, Jan. 2024, p. s319, https://doi.org/10.25251/skin.8.supp.319.